RENAGEL

Product NDC
68151-4295
11-digit product format
681514295
Labeler code
68151
Product ID
68151-4295_659e4de8-1232-4c9e-ab20-7e0d3af01700
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Renagel
Dosage form
TABLET
Route
ORAL
Labeler
Carilion Materials Management
Application
NDA021179
Marketing category
NDA
Marketing start
2008-06-06
Marketing end
0000-00-00
Substance
SEVELAMER HYDROCHLORIDE
Active strength
400 mg/1
Pharmacologic classes
Phosphate Binder [EPC],Phosphate Chelating Activity [MoA]
NDC exclude flag
No
Listing certified through
2019-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
5085f16b-f856-182d-a646-425b62d3f565Product name620251118
86e7ef73-ca63-701e-e952-6c80aa5122b8Product name920210309

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
68151-4295-1RENAGEL1 in 1 BLISTER PACKTABLET13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
68151-4295RENAGEL TABLET [CARILION MATERIALS MANAGEMENT]3Legacy NDC, 1 package rows20180215_9281598e-60de-4f4f-8e01-0a7dfef92dd3.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
857218RenaGel 400 MG Oral TabletPSN9281598e-60de-4f4f-8e01-0a7dfef92dd33
857216sevelamer HCl 400 MG Oral TabletPSN9281598e-60de-4f4f-8e01-0a7dfef92dd33
857218sevelamer hydrochloride 400 MG Oral Tablet [RenaGel]SBD9281598e-60de-4f4f-8e01-0a7dfef92dd33
857216sevelamer hydrochloride 400 MG Oral TabletSCD9281598e-60de-4f4f-8e01-0a7dfef92dd33
857218RenaGel 400 MG Oral TabletSY9281598e-60de-4f4f-8e01-0a7dfef92dd33

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionStatus
68151-4295-1681514295011 in 1 BLISTER PACKHistorical